| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
194 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,794 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,046 |
| 424/277.1 |
Cancer cell or component thereof |
385 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
209 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
134 |
| 424/193.1 |
Conjugate or complex |
846 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
970 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
468 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
250 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
245 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
585 |
| 424/204.1 |
Virus or component thereof |
999 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7125553 |
Methods of inducing immune tolerance using immunotoxins |
Oct. 24, 2006 |
| 7125542 |
Methods and compositions for treating conditions of the eye |
Oct. 24, 2006 |
| 7122370 |
Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life |
Oct. 17, 2006 |
| 7122197 |
Compounds from Moraxella catarrhalis |
Oct. 17, 2006 |
| 7122196 |
Compounds and methods for diagnosis of tuberculosis |
Oct. 17, 2006 |
| 7122194 |
Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs |
Oct. 17, 2006 |
| 7119248 |
Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof |
Oct. 10, 2006 |
| 7118924 |
Method for producing human antibodies in SCID mice which uses dendritic cells pulsed with antigen-antibody complexes and antigen-antibody complexes as immunizing agents |
Oct. 10, 2006 |
| 7118757 |
Meningococcal class 1 outer-membrane protein vaccine |
Oct. 10, 2006 |
| 7118756 |
Recombinant protective protein from Streptococcus pneumoniae |
Oct. 10, 2006 |
| 7118749 |
Transferrin receptor genes |
Oct. 10, 2006 |
| 7118747 |
AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents |
Oct. 10, 2006 |
| 7118746 |
Conditioned cell culture medium compositions and methods of use |
Oct. 10, 2006 |
| 7115361 |
Detection of CD8+ T cell responses to M. tuberculosis |
Oct. 3, 2006 |
| 7115269 |
Attenuated Salmonella strain used as a vehicle for oral immunization |
Oct. 3, 2006 |
| 7115268 |
Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
Oct. 3, 2006 |
| 7112655 |
JTT-1 protein and methods of inhibiting lymphocyte activation |
Sep. 26, 2006 |
| 7112566 |
Systemic administration of Hypocretin-1 |
Sep. 26, 2006 |
| 7109025 |
Viral vectors and viral vaccines based on recombinant porcine adenoviruses |
Sep. 19, 2006 |
| 7108852 |
Methods of treating inflammation using antibodies to M-CSF |
Sep. 19, 2006 |
| 7105155 |
Method and activated lymphocyte preparations for preventing recurrence of carcinoma |
Sep. 12, 2006 |
| 7105161 |
Proteinaceous adjuvants |
Sep. 12, 2006 |
| 7105170 |
Latent human tuberculosis model, diagnostic antigens, and methods of use |
Sep. 12, 2006 |
| 7105171 |
Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
Sep. 12, 2006 |
| 7101553 |
Immune response enhancement methods |
Sep. 5, 2006 |
| 7101556 |
Preparation and usage of plasmodium fusion antigen |
Sep. 5, 2006 |
| 7101562 |
Conjugate vaccines for the prevention of dental caries |
Sep. 5, 2006 |
| 7101676 |
Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA |
Sep. 5, 2006 |
| 7101963 |
Chlamydia pneumoniae polypeptides and uses thereof |
Sep. 5, 2006 |
| 7101989 |
DsrA protein and polynucleotides encoding the same |
Sep. 5, 2006 |
| 7097837 |
Synthetic vaccine agents |
Aug. 29, 2006 |
| 7097846 |
35 kD tumor associated protein antigen: uses and methods of detection |
Aug. 29, 2006 |
| 7094391 |
Compositions and methods for administering Borrelia burgdorferi antigens |
Aug. 22, 2006 |
| 7094396 |
Method for making cytokine specific antibodies and uses thereof |
Aug. 22, 2006 |
| 7094409 |
Antigen arrays for treatment of allergic eosinophilic diseases |
Aug. 22, 2006 |
| 7094419 |
Method of obtaining immune cells from an animal |
Aug. 22, 2006 |
| 7094552 |
Diagnostic test kits |
Aug. 22, 2006 |
| 7094946 |
Animal model for allergic disorders |
Aug. 22, 2006 |
| 7090847 |
Mammalian cytokines; related reagents and methods |
Aug. 15, 2006 |
| 7090980 |
Method of detecting acid-fast bacteria using ribosomal RNA as target |
Aug. 15, 2006 |
| 7091176 |
Methods for treating arthritis pain |
Aug. 15, 2006 |
| 7091315 |
Protein HDPBQ71 |
Aug. 15, 2006 |
| 7087231 |
Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
Aug. 8, 2006 |
| 7087235 |
Fusion protein of streptococcal pyrogenic exotoxins |
Aug. 8, 2006 |
| 7087236 |
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof |
Aug. 8, 2006 |
| 7087372 |
Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
Aug. 8, 2006 |
| 7083787 |
Yeast-dendritic cell vaccines and uses thereof |
Aug. 1, 2006 |
| 7083796 |
Fusion proteins of mycobacterium tuberculosis |
Aug. 1, 2006 |
| 7083797 |
32-kDa protein derived from Mycobacterium tuberculosis and related peptides |
Aug. 1, 2006 |
| 7084239 |
Cancer peptides of NY-ESO-1/CAG-3 |
Aug. 1, 2006 |
|
|
|
